Academic literature on the topic 'Hypersignaux de la substance blanche'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hypersignaux de la substance blanche.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Hypersignaux de la substance blanche"
Dalloz, M. A., R. Debs, C. Bensa, and S. Alamowitch. "Hypersignaux de la substance blanche révélant un pseudoxanthome élastique." Revue Neurologique 166, no. 10 (October 2010): 844–48. http://dx.doi.org/10.1016/j.neurol.2010.01.015.
Full textPallix-Guyot, M., B. Laudier, C. Ozsancak, and C. Magni. "Hypersignaux de la substance blanche : et si c’était une Maladie de Steinert ?" Revue Neurologique 169 (April 2013): A33. http://dx.doi.org/10.1016/j.neurol.2013.01.070.
Full textMotte, Marine Boudot De La, Maria Del Mar Amador, Savine Vicart, Dominique Bourgeois, Catherine Lubetzki, and Martin Catala. "Hypersignaux de la substance blanche et microdélétion 6p25 : à propos d’un cas." Revue Neurologique 172 (April 2016): A128. http://dx.doi.org/10.1016/j.neurol.2016.01.301.
Full textRouffiange-Leclair, L., F. Schneider, J. C. Antoine, F. G. Barral, and C. Boutet. "L’évaluation visuelle des hypersignaux de la substance blanche lies à l’âge par les neuroradiologues est-elle reproductible ?" Journal of Neuroradiology 39, no. 1 (March 2012): 19–20. http://dx.doi.org/10.1016/j.neurad.2012.01.055.
Full textMebrouk, Yassine, and Mounia Ettayeb. "Les étiologies des hypersignaux de la substance blanche sur la séquence T2 : comment arriver à un diagnostic ?" Revue Neurologique 172 (April 2016): A131. http://dx.doi.org/10.1016/j.neurol.2016.01.309.
Full textGarnier-Crussard, A., V. Desestret, F. Cotton, G. Chételat, and P. Krolak-Salmon. "Hypersignaux de la substance blanche chez la personne âgée : physiopathologie, troubles cognitifs associés et pistes de prévention." La Revue de Médecine Interne 41, no. 7 (July 2020): 475–84. http://dx.doi.org/10.1016/j.revmed.2020.02.009.
Full textSoumaré, A., A. Elbaz, P. Maillard, F. Crivello, B. Tavernier, C. Dufouil, B. Mazoyer, and C. Tzourio. "Hypersignaux de la substance blanche et performances motrices chez des sujets âgés de 65 à 85 ans." Revue d'Épidémiologie et de Santé Publique 56, no. 5 (September 2008): 315. http://dx.doi.org/10.1016/j.respe.2008.06.195.
Full textGodin, O., C. Dufouil, B. Mazoyer, F. Crivello, A. Alperovitch, and C. Tzourio. "B2-3 - Relation entre hypersignaux de la substance blanche et dépression chez les personnes âgées. Étude 3C — Dijon." Revue d'Épidémiologie et de Santé Publique 54 (August 2006): 19. http://dx.doi.org/10.1016/s0398-7620(06)76799-2.
Full textPeres, Roxane, Reynhold Schmidt, Stefan Ropele, Marco Duering, Martin Dichgans, Hugues Chabriat, and Eric Jouvent. "Les hypersignaux de la substance blanche sont-ils liés à de l’œdème cérébral dans les maladies des petites artères cérébrales ?" Revue Neurologique 171 (April 2015): A44. http://dx.doi.org/10.1016/j.neurol.2015.01.095.
Full textFerradji, Amel, Gayané Meliksetyan, and Christophe Vandendries. "Séquelles neurologiques et hypersignaux T2 de la substance blanche dans le cadre d’une épilepsie occipitale secondaire à une hyperglycémie sans cétone." Revue Neurologique 174 (April 2018): S19—S20. http://dx.doi.org/10.1016/j.neurol.2018.01.044.
Full textDissertations / Theses on the topic "Hypersignaux de la substance blanche"
Maillard, Pauline. "Vieillissement et hypersignaux de la substance blanche : Détection automatique et application à l'analyse de grandes cohortes." Caen, 2008. http://www.theses.fr/2008CAEN2041.
Full textThe increase of life expectancy during the last century has led to a growing number of dementia cases in the aging population. This incidence has reinforced the importance of characterizing the mechanisms of the normal brain aging. Among them, White Matter Hyperintensities (WMH) are a strong marker of vascular diseases and explain, in parts, cognitive decline observed in individuals aged 65 years and over. We have developed an automated algorithm for the detection, quantification, localization and mapping WMH using T1-, T2- and PD- (proton density) weighted MRI. This algorithm was applied to the analysis of two large MRI databases: EVA (Etude du Vieillissement Artériel) and 3C (Etude des 3 Cités). The reliability of the whole procedure was assessed by the comparison of WMH load estimated with a conventional visual inspection approach and by investigating whether previously reported associations still hold with the WMH load detected by our algorithm. We finally tested the inter-centre reproducibility the method by comparing WMH distributions and loads in the two samples and its robustness to different MRI parameters. In order to apply to longitudinal data, the method has been optimized to study individually the emergence of new WMH between the two trials and the development of WMH already existing at baseline. This study suggested that load of deep WMH was constant between the two sessions, contrary to juxtaventricular or periventricular WMH underlying that dichotomization of WMH based on physiological determinants has an etiological relevance. The results also indicated that development of existing WMH was larger with age, particularly in men, contrary to the emergence of new WMH that kept constant with aging. This original approach offer new possibilities to investigate the aetiology of WMH, still largely unknown, and to make their cognitive and motor consequences on aging population clearer
GICQUEL, SEBASTIEN. "Detection, quantification et localisation automatiques des hypersignaux de la substance blanche en imagerie par resonance magnetique." Caen, 1998. http://www.theses.fr/1998CAEN2025.
Full textGarnier-Crussard, Antoine. "Hypersignaux de la substance blanche dans la maladie d’Alzheimer : étude in vivo de l’hétérogénéité physiopathologique et des conséquences cliniques." Electronic Thesis or Diss., Lyon 1, 2024. http://www.theses.fr/2024LYO10306.
Full textWhite matter hyperintensities (WMH) are common neuroradiological findings in ageing. These WMH have clinical implications, including an increased risk of neurocognitive disorders. Traditionally, the vascular origin of WMH has been accepted within the context of cerebral small vessel disease, positioning WMH as the vascular contribution to cognitive impairment and dementia. However, there is evidence supporting an alternative hypothesis that some WMH may not be purely of vascular origin, particularly in Alzheimer's disease (AD). The aim of this thesis was to elucidate the pathophysiological heterogeneity and clinical consequences of WMH in ageing and in AD. To achieve this, we first conducted a comprehensive literature review highlighting several arguments supporting the existence of AD-related WMH. Subsequently, we investigated the progression of WMH across the adult lifespan by examining healthy adults of all ages and found an increase in WMH as early as 20 years old, which were associated with lower cognition independently from amyloid pathology (Study 1). We further demonstrated that WMH, especially in posterior brain regions, were more extensive in individuals with AD compared to healthy controls, independent of vascular risk factors, suggesting a possible non-vascular origin for these lesions (Study 2). Finally, we aimed at identifying clues in vivo to highlight this heterogeneity and the existence of AD-related WMH. We showed that intra-WMH multimodal neuroimaging signals appeared as a promising approach (Study 3). Collectively, these studies support the hypothesis of WMH heterogeneity during ageing and in the context of AD
Mortamais, Marion. "Facteurs influençant les relations entre les hypersignaux de la substance blanche cérébrale et le risque de troubles cognitifs et de démence chez les sujets âgés." Thesis, Montpellier 1, 2013. http://www.theses.fr/2013MON1T009/document.
Full textCerebral white matter hyperintensities (WMH), detected in vivo with MRI, are commonly used to assess cerebrovascular burden in cognitive impairment. However, the association between WMH and cognition is not consistent the across literature. In our longitudinal population-based study of 660 subjects aged 65 years and over with a brain MRI at baseline (ESPRIT Study), we aimed to identify factors that may modulate the effects of WMH on cognition. During the 10-year follow-up period, we observed that the association between WMH and cognitive impairment became weaker with advancing age, was only observed when the relationship was examined in low-educated individuals, and in patients with a specific spatial distribution of WMH, defined by a severe total WMH load with a high proportion of hyperintensities in the temporal lobe. These results suggest that there is a particular population (younger, less educated and with a specific distribution of WMH) in which the effects of WMH are more severe and/ or more easily detectable. In future studies using WMH as a marker of vascular burden in cognition, this particular population should be specifically considered
Djabelkhir, Jemmi Leila. "Prise en charge non pharmacologique des troubles cognitifs légers : effets différentiels d'un programme de stimulation cognitive informatisée selon la sévérité des hypersignaux de la substance blanche de patients MCI." Thesis, Sorbonne Paris Cité, 2017. http://www.theses.fr/2017USPCB241.
Full textWhite matter hyper signals (WMH) were associated with executive and memory deficits and impairment of the cortical and subcortical frontal circuits. Their presence, in addition to amyloid deposition in many patients with Mild Cognitive Impairment (MCI), would increase the risk of conversion to Alzheimer's disease (AD). An important issues in the preclinical phase of MCI is to explore the potential of cognitive interventions to prevent cognitive decline and progression to AD. While WMH are increasingly considered as one of factors determining the heterogeneity of MCI patients, few studies have take into account their presence in cognitive interventions. The hypothesis that an intervention could induce differential effects according to the existence or not of WMH in MCI remains unexplored to our knowledge, and is at the heart of this work of thesis
Watfa, Ghassan. "Altération vasculaire, hypertension et troubles cognitifs." Thesis, Nancy 1, 2011. http://www.theses.fr/2011NAN10066/document.
Full textThe role of the vascular alterations in the pathogenesis of cognitive impairment and dementia (vascular or Alzheimer) is increasingly recognized. In this context, we studied the epidemiological, physiological, genetic and therapeutic aspects of the relationship between high blood pressure, markers of arterial aging and cognitive impairment in elderly (aged 60-85 years) hypertensive patients with subjective memory complaints (ADELAHYDE study) and in institutionalized elderly subjects (aged >= 80 years) during one year follow-up (PARTAGE study), as well as in an elderly population (aged >= 60 years) with good general health and without dementia (Senior examination study). Our results on these three populations show that markers of arterial aging identified subjects at higher risk for cognitive decline, while blood pressure alone did not appear to have a significant predictive value. We also showed that in elderly hypertensive patients (ADELAHYDE study), treatment with calcium-channel blockers was associated with better cognitive performance, independently of blood pressure level and macrovascular or microvascular alteratios. This suggests a specific neuroprotective effect of channel blockers class in the elderly population. Lastly, we could not identify genetic factors associated with cognitive function
Cognat, Emmanuel. "Lésions de la substance blanche dans la maladie CADASIL." Thesis, Sorbonne Paris Cité, 2016. http://www.theses.fr/2016USPCC139/document.
Full textCADASIL is an autosomal dominant, hereditary, small vessel disease of the brain causing early and progressive white matter lesions. The histopathological characteristics of these lesions remain poorly known. The disease is caused by stereotyped mutations in the gene coding for the NOTCH3 receptor. One of CADASIL hallmarks is the presence in vessels of an abnormal accumulation of NOTCH3 extracellular domain (NOTCH3ECD). Data suggest that CADASIL pathophysiological process may be caused by a toxic effect resulting from NOTCH3ECD deposits, due to an abnormal recruitment of other extracellular matrix components. However, it has been shown that CADASIL mutations differentially affect Notch3 signaling, constitutively or progressively. The latter observations led scientists to propose the hypothesis that Notch3 loss of function may play an important role in CADASIL pathogenesis.We conducted a detailed white matter analysis in a CADASIL mouse model that overexpresses a Notch3 allele with the R169C/R170C mutation and that recapitulates the preclinical stages of the disease (TgPACNotch3R169C). In this model, we observed intramyelinic edema associated with myelin degradation / decompaction detectable by immunochemistry in the brain of mice as young as 6 months of age. Axonal integrity analysis in myelin lesions suggested that axonal loss may appear secondarily. A semi-quantitative method for the quantification of myelin debris has been developed.Next, we tested the hypothesis that Notch3 loss of function might play a key role in CADASIL pathophysiology. We first identified a set of genes that are sensitive to a reduction in Notch3 dosage by half. Quantification of these genes expression in both heterozygous and homozygous mice Knock-in for the R170C mutation showed that Notch3 activity was not lowered in this model. In addition, we analyzed the effect of a suppression of endogenous Notch3 copies on white matter lesions observed in TgPACNotch3R169C mice and observed no worsening of these lesions. Together these results suggest that hypomorphism is not a feature common to all CADASIL mutations, and that white matter lesions in CADASIL do no result from Notch3 loss of function.Finally, we studied the pathogenic effect of Timp3 and vitronectine accumulation, both proteins having been shown to accumulate with NOTCH3ECD early in the course of the disease. By the use of genetic interaction approaches (lowering and increase in Timp3 and vitronectine in TgPACNotch3R169C mice), we observed differential effects of the proteins on white matter lesions and cerebrovascular reactivity impairment. Indeed, vitronectine lowering improves white matter lesions without any effect on cerebrovascular reactivity while Timp3 diminution restores cerebrovascular reactivity without any effect on white matter lesions. These results provide proof of concept for the implication of TIMP3 and vitronectin excess in CADASIL pathogenesis and questions the dogma that make hypoperfusion the main determinant of white matter lesions in CADASIL
Saba, Yasaman. "Déterminants génétiques des marqueurs IRM du vieillissement vasculaire cérébral." Electronic Thesis or Diss., Bordeaux, 2024. http://www.theses.fr/2024BORD0466.
Full textOver the last century, life expectancy has increased dramatically, contributing to a sharp increase in the number of patients with common neurological disease, especially stroke and dementia. Mounting evidence suggests that early life factors, including genetic factors, play a crucial role in the occurrence of such diseases. Cerebral small vessel disease (cSVD) is a major cause of stroke, cognitive decline and dementia. cSVD is most often covert, detectable on brain images in the absence of clinical manifestations. Brain magnetic resonance imaging (MRI) markers of cSVD, which can be measured non-invasively in large population, can provide crucial insights into the cause of late-life neurological diseases. White matter hyperintensities (WMH), lacunes, cerebral microbleeds, and perivascular spaces are the most commonly studied MRI-markers of cSVD, while diffusion tensor imaging (DTI) offers new opportunity to explore susceptibility to cSVD across the lifespan. Deciphering these genetic risk factors of cSVD, including in early life, is a powerful tool to decipher molecular mechanisms leading to this disease. In this thesis, we explored the genetic determinants of MRI-markers of cSVD in the general population across the lifespan, by conducting large collaborative meta-analyses of genome-wide association studies (GWAS) in up to 58,403 participants from the general population. First, we conducted a GWAS of WMH stratified on hypertension status. Our results shed new light into modifying effects of high blood pressure on genetic susceptibility to WMH. Second, we examined the genetic underpinnings of an emerging DTI marker, peak width of skeletonized mean diffusivity (PSMD), by conducting the first GWAS of PSMD, across the lifespan. We identified up to 25 novel genetic risk loci for PSMD, with good effect size correlation across European and East-Asian ancestries. Additionally, in a whole-exome association study (derived from whole exome sequencing), rare variants and burden of rare loss-of-function or singleton variants in 4 different genes were associated with PSMD. Genetically determined larger volume of WMH was associated with higher PSMD from early childhood to older age. Moreover, common PSMD risk loci were enriched in genes expressed in fetal brain endothelial cells. In conclusion, this work provides new insights into complex genomics of cSVD across the lifespan, across ancestries, and in interaction with hypertension, the most common risk factor of cSVD. These results are informative for the development of efficient preventive and therapeutic strategies for cSVD and its complications, a major public health challenge
Samaille, Thomas. "Segmentation automatique des anomalies de la substance blanche du sujet âgé." Paris 6, 2013. http://www.theses.fr/2013PA066162.
Full textUszynski, Ivy. "Identification et caractérisation des faisceaux de substance blanche en IRM : développements précliniques." Thesis, Université Grenoble Alpes (ComUE), 2018. http://www.theses.fr/2018GREAY075/document.
Full textMagnetic resonance imaging (MRI) allows the observation of the major white matter fiber tracts in the brain. It can thus be used in many applications to have a better understanding of the development of healthy and pathological brains and to study the effect of potential therapeutic treatments. In order to observe these fibers, one must combine a today well-controlled MRI acquisition with a data processing procedure that is still under investigation for many research projects. To characterize those fibers whose diameters are only a few microns wide, the MRI spatial resolution must be raised beyond the spatial resolution of the acquisition. This super-resolution achievement can be obtained by combining biophysical models with several measures of the MRI signal. Together, one can gain access to axon diameter measures for example, as was done by Assaf in 2008 (AxCaliber approach). One of the interests of this measure is its correlation with the conduction velocity of the electric signals (Horowitz 2015). These methodological developments are mainly done in human research. However, many animal models are used to understand the healthy as well as the pathological brains. In the context of a collaboration between team UNIRS of NeuroSpin (Cyril Poupon) and team 5 of GIN (Grenoble Institute of Neuroscience) (Emmanuel Barbier), we have initiated the transfer for the mouse of the tools currently used for human
Book chapters on the topic "Hypersignaux de la substance blanche"
Thines, L. "Anatomie cérébrale : substance blanche." In Atlas Interactif de Neuroanatomie Clinique, 39–45. Elsevier, 2016. http://dx.doi.org/10.1016/b978-2-294-74694-9.00004-9.
Full textDietemann, J. L., M. Koob, S. Kremer, and A. Bogorin. "Pathologie de la substance blanche." In Neuro-Imagerie Diagnostique, 537–94. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-75394-7.00016-3.
Full textBaud, O. "Lésions de la substance blanche." In Réanimation et Soins Intensifs en Néonatologie, 593–97. Elsevier, 2024. http://dx.doi.org/10.1016/b978-2-294-77019-7.00098-5.
Full textDietemann, J. L., M. Koob, S. Kremer, and A. Bogorin. "Pathologie de la substance blanche." In Neuro-imagerie diagnostique, 563–627. Elsevier, 2012. https://doi.org/10.1016/b978-2-294-71452-8.00016-4.
Full textHausser-Hauw, Chantal. "Lésions vasculaires multiples de la substance blanche (maladie de Binswanger et CADASIL)." In Manuel d'EEG de l'adulte. Veille et sommeil, 271. Elsevier, 2007. http://dx.doi.org/10.1016/b978-2-294-07145-4.50063-5.
Full text